SampleIDwithtype,Fname,Lname,DOB,Organism,Resistance,SuspectedPneumonia?,onVentattimeofsamplecollection?,InICUattimeofsamplecollection?,Age,Race,Gender,ClinicalsignsofHAP/VAP/HCAP,HAP,HCAP,VAP,WBC,Hematocrit,PlateletCount,Potassium,Creatinine,TotalBilirubin,Lactate,Procalcitonin,C-reactiveProtein,PaO2,FiO2,Temperature,RespiratoryRate,BloodPressure,HR,GCS,CryptococcusAntigen,CoccidioidesAbIgg,StrepPneumoUrAgn,Cough/Sputum,Dyspnea,Admitted,Admissionlocation,Workinginpatientdiagnosis,Antibioticsgivenpreculture,Otherantibioticsgivenpostcultureresults,Antibioticsprescribedondischarged,CultureType1,CultureDate1,Cultureresult1,CultureType2,CultureDate2,Cultureresult2,CultureType3,CultureDate3,Cultureresult3,CultureType4,CultureDate4,Cultureresult4,Radiographicscantype1,RadiographicScanDate1,Radiographiimpression1,Category1,Radiographicscantype2,RadiographicScanDate2,Radiographiimpression2,Category2,Radiographicscantype3,RadiographicScanDate3,Radiographiimpression3,Category3
ETA294,Lars Durham,Sanders,8/7/2015,Gram Stain <<:>>Good 2/2/2015 specimen<<:>>Moderate Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>Very light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture (HH)<<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Moderate<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Enterobacter cloacae<<:>>Light<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Moderate<<:>>second morphology;<<:>><<:>><<:>><<:>>,<<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Pseudomonas aeruginosa (1)<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>><=8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>4/4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Enterobacter cloacae<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>><=8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefazolin<<:>><<:>>>16 ug/mL<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>><=1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefoxitin<<:>><<:>>>16 ug/mL<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>>>32 ug/mL<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ertapenem<<:>><<:>>0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>8/4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>><=0.5/9.5 u...<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Pseudomonas aeruginosa (3)<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>><=8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>4/4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>>,yes,yes,yes,64,B,M,treated for VAP per notes,no,no,yes,14.54,24.7,188,4.1,2.3,2.5,1.7,n/a,n/a,72,40,37.6,31,106/62,90,9,n/a,n/a,n/a,no,yes,yes,SICU,VAP,Fluconazole( 13 days)<<.>> vancomycin( 3 days)<<.>> zosyn( 13 days),cipro(6 days),none,Respiratory,T + 7,"Gram Stain <<:>>Heavy Polymorphonuclear Leukocytes<<:>>No squamous epithelial cells<<:>>No organisms seen.<<:>><<:>><<:>>Respiratory Culture (HH)<<:>>Respiratory Culture <<:>>Enterobacter cloacae<<:>>3000 CFU/mL<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Enterobacter cloacae<<:>>2000 CFU/mL<<:>>second morphology;<<:>> (HH)VC<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>>10<<.>>000 CFU/mL<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>>10<<.>>000 CFU/mL<<:>>second morphology;<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Stenotrophomonas maltophilia<<:>>4000 CFU/mL<<:>>Susceptibility <<:>>  Enterobacter cloacae (1)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Ampicillin 16 ug/mL"">>16 ug/mL R<<:>> Ampicillin + Sulbactam 16/8 ug/mL"">>16/8 ug/mL R<<:>> Aztreonam <=2 ug/mL S<<:>> Cefazolin 16 ug/mL"">>16 ug/mL R<<:>> Cefepime <=1 ug/mL S<<:>> Cefoxitin 16 ug/mL"">>16 ug/mL R<<:>> Ceftazidime 1 ug/mL S<<:>> Ceftriaxone 16 ug/mL R<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Ertapenem <=0.25 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem <=0.5 ug/mL S<<:>> Piperacillin + Tazobactam 4/4 ug/mL S<<:>> Tetracycline <=2 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S<<:>>   <<:>><<:>>Susceptibility <<:>>  Enterobacter cloacae (2)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Ampicillin 16 ug/mL"">>16 ug/mL R<<:>> Ampicillin + Sulbactam 8/4 ug/mL S<<:>> Aztreonam <=2 ug/mL S<<:>> Cefazolin 16 ug/mL"">>16 ug/mL R<<:>> Cefepime <=1 ug/mL S<<:>> Cefoxitin 16 ug/mL"">>16 ug/mL R<<:>> Ceftazidime <=0.5 ug/mL S<<:>> Ceftriaxone <=1 ug/mL S<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Ertapenem <=0.25 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem <=0.5 ug/mL S<<:>> Piperacillin + Tazobactam <=2/4 ug/mL S<<:>> Tetracycline <=2 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (3)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 16 ug/mL"">>16 ug/mL R<<:>> Cefepime 16 ug/mL I<<:>> Ceftazidime 16 ug/mL"">>16 ug/mL R<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem 2 ug/mL S<<:>> Piperacillin + Tazobactam 64/4 ug/mL"">>64/4 ug/mL R<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (4)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 16 ug/mL I<<:>> Cefepime 8 ug/mL S<<:>> Ceftazidime 16 ug/mL"">>16 ug/mL R<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem 2 ug/mL S<<:>> Piperacillin + Tazobactam 64/4 ug/mL"">>64/4 ug/mL R<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Stenotrophomonas maltophilia<<:>>  MIC<<:>> Ceftazidime 1 ug/mL S<<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S<<:>><<:>><<:>><<:>><<:>>",n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,Chest<<.>> single view: Interval placement of the nasal duodenostomy tube <<:>>that is seen within the cervical esophagus at the thoracic inlet. <<:>>Endotracheal and enteric tubes unchanged. Left subclavian central line is <<:>>unchanged at the mid to upper superior vena cava. Bilateral thoracostomy <<:>>tubes unchanged.<<:>><<:>>The cardiac silhouette is normal. The thoracic aorta is tortuous. Stable <<:>>right basilar hazy opacity from pulmonary contusion. Multiple right-sided <<:>>rib fractures and subcutaneous emphysema unchanged.<<:>>,see impression,Chest xray,T  0,Bilateral chest tubes<<.>> endotracheal tube<<.>> enteric tube and left approach <<:>>PICC positions unchanged.<<:>>Bilateral upper lobe emphysematous changes.<<:>>Probable tiny right pleural effusion and new patchy right basal airspace <<:>>disease.<<:>>New opacity in left lower lobe near costophrenic angle.<<:>>Unchanged cardiomediastinal silhouette.<<:>>Multiple displaced right rib fractures ,see impression,Chest ct,T + 7,. Significantly enlarged extrapleural heterogenous collection within the <<:>>right hemithorax resulting in mediastinal shift. Given the clinical <<:>>history<<.>> appearances are concerning for interval hemorrhage.<<:>>2. Left hydropneumothorax has decreased in size.<<:>>3. Remaining additional findings including multiple fractures<<.>> right <<:>>renal calculus<<.>> and bilateral hyperattenuating renal lesions as described.<<:>>,see impression
ETA295,Quentin Mcclure,Walton,5/30/2016,Gram Stain <<:>>Adequate specimen<<:>>Light Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Heavy Gram Negative Bacilli<<:>>Moderate Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture Moderate Respiratory Flora (HH)<<:>>Respiratory Culture <<:>>Serratia marcescens<<:>>Moderate<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Moderate<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Stenotrophomonas maltophilia<<:>>Heavy<<:>><<:>><<:>><<:>>,"Susceptibility <<:>>  Serratia marcescens<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Ampicillin 16 ug/mL"">>16 ug/mL R<<:>> Ampicillin + Sulbactam 16/8 ug/mL"">>16/8 ug/mL R<<:>> Aztreonam 16 ug/mL R<<:>> Cefazolin 16 ug/mL"">>16 ug/mL R<<:>> Cefepime 2 ug/mL S<<:>> Cefoxitin 16 ug/mL"">>16 ug/mL R<<:>> Ceftazidime 4 ug/mL S<<:>> Ceftriaxone 32 ug/mL"">>32 ug/mL R<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Ertapenem 1 ug/mL I<<:>> Gentamicin 4 ug/mL S<<:>> Meropenem <=0.5 ug/mL S<<:>> Piperacillin + Tazobactam 64/4 ug/mL"">>64/4 ug/mL R<<:>> Tetracycline 8 ug/mL"">>8 ug/mL R<<:>> Tobramycin 8 ug/mL I<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 8 ug/mL S<<:>> Cefepime 16 ug/mL I<<:>> Ceftazidime 4 ug/mL S<<:>> Ciprofloxacin 2 ug/mL I<<:>> Gentamicin 8 ug/mL I<<:>> Meropenem 1 ug/mL S<<:>> Piperacillin + Tazobactam 16/4 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Stenotrophomonas maltophilia<<:>>  MIC<<:>> Ceftazidime 16 ug/mL"">>16 ug/mL R<<:>> Trimethoprim + Sulfamethoxazole 2/38 ug/mL S<<:>>   <<:>><<:>>",no(treatment for pneumonia conclududed more than 1 week before sample collection),no(trach collar),yes,19,B,F,none,no,no,no,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,50,36.5,33,125/59,100,15,n/a,n/a,n/a,no,yes,yes,Peds ICU,no id diagnosis,none,none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 6,The lungs remain hyperinflated. Vague opacity right base is likely minor <<:>>atelectasis<<.>> more apparent than on a prior study from one day before. The <<:>>heart is normal in size. Two metallic rods course from the upper thoracic <<:>>through visualized lower thoracic spine. Tracheostomy tube in good <<:>>position. Tubing from a ventriculoperitoneal shunt crosses the right <<:>>hemithorax. Tip of baclofen pump catheter overlies lower thoracic level.<<:>>,see impression,Chest xray,T  0,Tracheostomy cannula tip lies at the thoracic inlet. The <<:>>lungs are well-expanded and clear. Normal heart size. Unremarkable <<:>>pleural spaces. VP shunt tubing on the right. Spinal fusion hardware is <<:>>intact. Baclofen pump catheter is demonstrated in the mid/lower thoracic <<:>>spine.<<:>>,see impression,n/a,n/a,n/a,n/a
ETA296,Keith Castillo,Clements,8/31/2016,Gram Stain <<:>>Adequate specimen<<:>>Light Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture (HH)<<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Heavy<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Heavy<<:>>second morphology;<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Stenotrophomonas maltophilia<<:>>Moderate<<:>><<:>><<:>><<:>>,"Susceptibility <<:>>  Pseudomonas aeruginosa (1)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 16 ug/mL"">>16 ug/mL R<<:>> Cefepime 2 ug/mL S<<:>> Ceftazidime 4 ug/mL S<<:>> Ciprofloxacin 2 ug/mL I<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem 8 ug/mL"">>8 ug/mL R<<:>> Piperacillin + Tazobactam 8/4 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (2)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 8 ug/mL S<<:>> Cefepime 2 ug/mL S<<:>> Ceftazidime 2 ug/mL S<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem <=0.5 ug/mL S<<:>> Piperacillin + Tazobactam 8/4 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Stenotrophomonas maltophilia<<:>>  MIC<<:>> Ceftazidime 16 ug/mL I<<:>> Trimethoprim + Sulfamethoxazole 1/19 ug/mL S<<:>><<:>>",yes,yes,yes,72,W,F, treated for VAP per notes,no,no,yes,3.12,32.6,400,4.7,0.6,<.2,n/a,n/a,n/a,107,50,36.7,20,149/60,78,5,n/a,n/a,n/a,no,yes,yes,NCCU,VAP,micafungin(1 day)<<.>> vancomycin(> 2 weeks)<<.>> zosyn( 3 days)<<.>> cipro( 5 days)<<.>> bactrim(5 days),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,Slight increase in opacity right lower lungs since<<:>>Endotracheal tube<<.>> nasogastric tube<<.>> left central venous catheter remain.<<:>>Mild cardiomegaly<<.>> stable.<<:>>Vascular congestion.<<:>>Bilateral patchy opacities and small to moderate bilateral pleural <<:>>effusions remain.<<:>>,see impression,Chest xray,T  0,Little change since <<:>>Endotracheal tube<<.>> esophageal probe<<.>> nasogastric tube<<.>> and left central <<:>>venous catheter remain in position.<<:>>Mild hypoinflation lungs.<<:>>Mild patchy edema persisting bilaterally.<<:>>Trace left pleural effusion ,see impression,Chest xray,T + 4,Interval placement of tracheostomy tube terminating in the trachea. <<:>>Previously present endotracheal tube<<.>> endogastric tube<<.>> and esophageal <<:>>probe are no longer present. Left subclavian central venous catheter <<:>>terminates at the cavoatrial junction.<<:>>Stable cardiomediastinal silhouette.<<:>>Clear visible lungs. No pneumothorax or pleural effusion.<<:>>,see impression
ETA297,Blaze Garner,Jacobs,2/10/2015,Gram Stain <<:>>Adequate specimen<<:>>Light Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture (HH)<<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Heavy<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Heavy<<:>>second morphology;<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Stenotrophomonas maltophilia<<:>>Moderate<<:>><<:>><<:>><<:>>,"Susceptibility <<:>>  Pseudomonas aeruginosa (1)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 16 ug/mL"">>16 ug/mL R<<:>> Cefepime 2 ug/mL S<<:>> Ceftazidime 4 ug/mL S<<:>> Ciprofloxacin 2 ug/mL I<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem 8 ug/mL"">>8 ug/mL R<<:>> Piperacillin + Tazobactam 8/4 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (2)<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 8 ug/mL S<<:>> Cefepime 2 ug/mL S<<:>> Ceftazidime 2 ug/mL S<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem <=0.5 ug/mL S<<:>> Piperacillin + Tazobactam 8/4 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Stenotrophomonas maltophilia<<:>>  MIC<<:>> Ceftazidime 16 ug/mL I<<:>> Trimethoprim + Sulfamethoxazole 1/19 ug/mL S<<:>><<:>>",yes,yes,yes,72,W,F, treated for VAP per notes,no,no,yes,3.12,32.6,400,4.7,0.6,<.2,n/a,n/a,n/a,107,50,36.7,20,149/60,78,5,n/a,n/a,n/a,no,yes,yes,NCCU,VAP,micafungin(1 day)<<.>> vancomycin(> 2 weeks)<<.>> zosyn( 3 days)<<.>> cipro( 5 days)<<.>> bactrim(5 days),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,Slight increase in opacity right lower lungs since<<:>>Endotracheal tube<<.>> nasogastric tube<<.>> left central venous catheter remain.<<:>>Mild cardiomegaly<<.>> stable.<<:>>Vascular congestion.<<:>>Bilateral patchy opacities and small to moderate bilateral pleural <<:>>effusions remain.<<:>>,see impression,Chest xray,T  0,Little change since <<:>>Endotracheal tube<<.>> esophageal probe<<.>> nasogastric tube<<.>> and left central <<:>>venous catheter remain in position.<<:>>Mild hypoinflation lungs.<<:>>Mild patchy edema persisting bilaterally.<<:>>Trace left pleural effusion ,see impression,Chest xray,T + 4,Interval placement of tracheostomy tube terminating in the trachea. <<:>>Previously present endotracheal tube<<.>> endogastric tube<<.>> and esophageal <<:>>probe are no longer present. Left subclavian central venous catheter <<:>>terminates at the cavoatrial junction.<<:>>Stable cardiomediastinal silhouette.<<:>>Clear visible lungs. No pneumothorax or pleural effusion.<<:>>,see impression
ETA298,Graham Mcpherson,Fuller,9/14/2016,Gram Stain <<:>>Adequate specimen<<:>>Light Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Moderate Gram Positive Cocci in Chains<<:>>Light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture Moderate Respiratory Flora (HH)<<:>>Respiratory Culture <<:>>Escherichia coli<<:>>Moderate<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Moderate<<:>><<:>><<:>><<:>>,<<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Escherichia coli<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>><=8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>><=4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin + Sulbactam<<:>><<:>>2/1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefazolin<<:>><<:>><=1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>><=1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefoxitin<<:>><<:>><=4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>><=1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ertapenem<<:>><<:>><=0.25 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>><=2/4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>><=0.5/9.5 u...<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Pseudomonas aeruginosa<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>><=8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>8 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>8/4 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>><=2 ug/mL<<:>><<:>>S<<:>>,no(on pneumonia prophalaxis at the time of sample collection),yes,yes,65,W,M,none,no,no,no,7.9,31.7,252,n/a,n/a,n/a,n/a,n/a,n/a,94,30,36.6,14,118/46,68,11,n/a,n/a,n/a,no,yes,yes,NCCU,wound infection,unclear,unclear,unclear,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,No significant change<<.>> allowing for differences in positioning.<<:>>Tracheostomy mid trachea.<<:>>Mildly elevated right hemidiaphragm.<<:>>Left subclavian central venous catheter tip at the level of the mid SVC.<<:>><<:>>,see impression,Chest xray,T + 7,Chest<<.>> one view: At least partial atelectasis left lower lobe appearing <<:>>since yesterday at 0431 hours. Removal left subclavian venous catheter. <<:>>No other change.<<:>>,see impression,n/a,n/a,n/a,n/a
ETA299,Keegan Mccullough,Lynch,2/17/2015,Gram Stain <<:>>Good specimen<<:>>Moderate Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>Heavy Gram Positive Diplococci<<.>> suggestive of Strep.pneumoniae<<:>>Quellung Positive<<:>><<:>><<:>><<:>>Respiratory Cult <<:>>Heavy Respiratory Flora<<:>>ORG 1:<<:>>Moderate Escherichia coli<<:>>ORG 2:<<:>>Heavy Streptococcus pneumoniae<<:>><<:>><<:>><<:>>,Susceptibility <<:>>  Escherichia coli<<:>>  MIC<<:>> Amikacin S<<:>> Ampicillin S<<:>> Ampicillin + Sulbactam S<<:>> Aztreonam S<<:>> Cefazolin S<<:>> Cefepime S<<:>> Cefoxitin S<<:>> Ceftazidime S<<:>> Ceftriaxone S<<:>> Ciprofloxacin R<<:>> Ertapenem S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tetracycline S<<:>> Tobramycin S<<:>> Trimethoprim + Sulfamethoxazole S<<:>>   <<:>><<:>>Susceptibility <<:>>  Streptococcus pneumoniae<<:>>  MIC<<:>> AMOXICILLIN S<<:>> Ceftriaxone S<<:>> Clindamycin S<<:>> Erythromycin S<<:>> Moxifloxacin S<<:>> Penicillin G S<<:>> Tetracycline S<<:>> Trimethoprim + Sulfamethoxazole S<<:>> Vancomycin S<<:>><<:>>,yes,yes,yes,53,O,F, treated for VAP per notes,no,no,yes,15.29,32.6,203,n/a,n/a,n/a,n/a,n/a,n/a,150,50,38.4,30,147/70,83,unclear,n/a,n/a,n/a,yes,yes,yes,NCCU,pneumonia,ceftriaxone(6 days),vancomycin(1 day),none,Respiratory,T + 2,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Very light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Cult <<:>>Very Light Respiratory Flora<<:>>ORG 1:<<:>>Very Light Yeast<<.>> not Cryptococcus neoformans<<:>><<:>><<:>><<:>>,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,Endotracheal tube tip above the carina. NG tube present. No focal <<:>>infiltrate or congestion. Borderline cardiomegaly <<:>>,see impression,Chest xray,T  0,No significant interval change. <<:>><<:>>Lines and tubes appear stable in position. <<:>>Right infrahilar opacity<<.>> may relate to atelectasis or early pneumonia. <<:>>Borderline cardiomegaly. <<:>>Minimal atelectasis in the left lung base. <<:>><<:>>,possible pneumonia,Chest xray,T + 7,Interval placement of tracheostomy tube and removal of nasogastric tube. <<:>><<:>>Otherwise<<.>> no significant interval change. <<:>><<:>>Left subclavian central venous catheter with tip near the superior <<:>>cavoatrial junction. <<:>>Mild patchy opacities within the lungs. <<:>>Mild cardiomegaly. <<:>>,see impression
ETA300,Marshall Hull,Sears,12/11/2015,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Very light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture Very Light Respiratory Flora (HH)<<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Moderate<<:>><<:>><<:>><<:>>,Susceptibility <<:>>  Pseudomonas aeruginosa<<:>>  MIC BP<<:>> Amikacin <=8 ug/mL S <<:>> Aztreonam 4 ug/mL S <<:>> Cefepime 4 ug/mL S <<:>> Ceftazidime 1 ug/mL S <<:>> Ciprofloxacin  1 ug/mL S<<:>> Gentamicin <=2 ug/mL S <<:>> Meropenem <=0.5 ug/mL S <<:>> Piperacillin + Tazobactam 8/4 ug/mL S <<:>> Tobramycin <=2 ug/mL S <<:>><<:>>,unclear,unclear,unclear,17,W,M,unclear,unclear,unclear,,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,unclear,unclear,unclear,unclear,unclear,unclear,n/a,n/a,n/a,unclear,unclear,yes,unclear,unclear,unclear,unclear,unclear,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA301,Kenyon Hendrix,Lowe,6/16/2015,<<:>>Gram Stain<<:>><<:>> <<:>><<:>><<:>>Good specimen <<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial <<:>>Cells <<:>>Heavy Gram Negative Diplococci <<:>>Moderate Normal Upper Respiratory Flora <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>> <<:>><<:>><<:>>Moderate Respiratory Flora <<:>>ORG 1: <<:>>Heavy Pseudomonas aeruginosa <<:>>ORG 2: <<:>>Heavy Pseudomonas aeruginosa <<:>>second morphology; <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Pseudomonas aeruginosa <<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Pseudomonas aeruginosa <<:>>,Susceptibility <<:>>  Pseudomonas aeruginosa (2.1)<<:>>  MIC<<:>> Amikacin S<<:>> Aztreonam S<<:>> Cefepime S<<:>> Ceftazidime S<<:>> Ciprofloxacin S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tobramycin S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (2.2)<<:>>  MIC<<:>> Amikacin S<<:>> Aztreonam S<<:>> Cefepime S<<:>> Ceftazidime S<<:>> Ciprofloxacin S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tobramycin S<<:>><<:>>,yes,yes,yes,56,A,M,signs of pneumonia present < 48 hours after admission,no,no,no,5.85,25.6,78,6.1,9.8,0.8,n/a,n/a,n/a,98.7,40,36.9,25,93/42,98,unclear,n/a,n/a,n/a,no,yes,yes,MICU,pneumonia,cefepime(4 days),azithromycin(1 day)<<.>> zosyn(1 day)<<.>> vancomycin(3 days),none,Respiratory,T + 3,Gram Stain <<:>>Good specimen<<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial<<:>>Cells<<:>>Moderate Gram Negative Bacilli<<:>><<:>><<:>>Respiratory Cult <<:>>Very Light Respiratory Flora<<:>>ORG 1:<<:>>Heavy Pseudomonas aeruginosa<<:>><<:>><<:>>Respiratory Cult Pseudomonas aeruginosa<<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Pseudomonas aeruginosa<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>>S<<:>>,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,Interval placement of double-lumen endotracheal tube<<.>> one lumen <<:>>terminating at the level of the aortic knob and the other selectively <<:>>within the left mainstem bronchus. <<:>>Otherwise no significant change<<.>> with patchy opacities in the right lung <<:>><<:>>and pleural thickening at the right apex. <<:>>,see impression,Chest ct,T + 4,1. Significant consolidation<<.>> scattered tree in bud opacities<<.>> scattered <<:>><<:>>ground glass opacities throughout the lungs<<.>> worse in the lower lobes<<.>> <<:>>consistent with pneumonia. Multiple air cysts are present within the <<:>>right upper lung and some contain debris suspicious for fungal infection <<:>><<:>>such as a mycetoma. Many of these lung cysts in the right upper lobe <<:>>demonstrate air-fluid levels<<.>> as well<<.>> and are likely infected. Given the <<:>><<:>>degree of consolidation and nodular opacities<<.>> underlying malignancy is <<:>><<:>>not ruled out in these regions. Overall<<.>> this is significantly worsened. ,pneumonia,n/a,n/a,n/a,n/a
ETA302,Vance Fulton,Cherry,2/2/2016,Gram Stain <<:>>Good specimen<<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial<<:>>Cells<<:>>Heavy Normal Upper Respiratory Flora<<:>><<:>><<:>>,n/a,yes,yes,yes,51,W,M,signs of pneumonia present on day 1 of admission,no,no,no,21.52,21.8,460,3.6,3.5,0.3,n/a,n/a,n/a,75.4,100,35.4,20,87/76,109,unclear,n/a,n/a,n/a,no,yes,yes,MICU,pneumonia,ampicillin(1 day)<<.>> meropenem( 3 days)<<.>> vanocmycin(3 days),linezolid(1 day),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest ct,T  0,1. Extensive multifocal pneumonia as described <<:>><<:>>2. Moderate bilateral hydronephrosis with bilateral nephroureteral stents <<:>><<:>>inserted since prior. Stents maybe malfunctioning. <<:>><<:>>3. Foley catheter in place with evidence of chronic cystitis. Correlate ,pneumonia,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA303,Rajah George,Roach,1/8/2015,Gram Stain <<:>>Adequate specimen<<:>>Moderate Polymorphonuclear Cells and Light Squamous Epithelial Cells<<:>>Moderate Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Cult <<:>>Heavy Respiratory Flora<<:>>ORG 1:<<:>>Heavy Staphylococcus aureus<<:>><<:>><<:>>Respiratory Cult STAPHYLOCOCCUS AUREUS<<:>><<:>>,Susceptibility <<:>>  Staphylococcus aureus<<:>>  MIC<<:>> Clindamycin S<<:>> Erythromycin I<<:>> Moxifloxacin S<<:>> Oxacillin S<<:>> Tetracycline S<<:>> Trimethoprim + Sulfamethoxazole S<<:>> Vancomycin S<<:>>   <<:>><<:>>,yes,no,yes,82,O,F,treated for HCAP ,no,yes,no,7.11,31.8,123,4.1,0.9,0.5,n/a,n/a,n/a,151,27,37.5,18,107/61,106,unclear,n/a,n/a,n/a,no,yes,yes,MICU,pneumonia,cefepime(4 days)<<.>> bactrim( 1 day),amoxicillin(4 days)<<.>> vancomycin( 4 days),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,. Massive left-sided pleural effusion with complete left lung collapse <<:>><<:>>without definitive evidence of malignancy. Recommend correlation with <<:>>thoracentesis. <<:>><<:>>2. No right-sided effusion or significant abnormality identified <<:>><<:>>3. Other chronic findings as described above <<:>>,see impression,Chest xray,T + 4,finding seen previously. Given the <<:>>significant left effusion underlying mass cannot be excluded was noted on <<:>><<:>>recent CT chest. Probably is associated compressive atelectatic change. <<:>><<:>>Pacer as before. Effusion has not changed significantly. Right lung is <<:>>clear <<:>>,see impression,n/a,n/a,n/a,n/a
ETA304,Levi Maldonado,Mcconnell,4/28/2016,Gram Stain <<:>>Adequate specimen<<:>>Very Light Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>No organisms seen.<<:>><<:>><<:>>Respiratory Culture Light Respiratory Flora (HH)<<:>>Respiratory Culture <<:>>Enterobacter cloacae<<:>>Light<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Haemophilus influenzae<<:>>Light<<:>>Beta lactamase negative<<:>><<:>><<:>>,"Susceptibility <<:>>  Enterobacter cloacae<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Ampicillin 16 ug/mL"">>16 ug/mL R<<:>> Ampicillin + Sulbactam R<<:>> Aztreonam <=2 ug/mL S<<:>> Cefazolin 16 ug/mL"">>16 ug/mL R<<:>> Cefepime <=1 ug/mL S<<:>> Cefoxitin 16 ug/mL"">>16 ug/mL R<<:>> Ceftazidime <=0.5 ug/mL S<<:>> Ceftriaxone <=1 ug/mL S<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Ertapenem <=0.25 ug/mL S<<:>> Gentamicin <=2 ug/mL S<<:>> Meropenem <=0.5 ug/mL S<<:>> Piperacillin + Tazobactam 4/4 ug/mL S<<:>> Tetracycline <=2 ug/mL S<<:>> Tobramycin <=2 ug/mL S<<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S<<:>>   <<:>><<:>>Susceptibility <<:>>  Haemophilus influenzae<<:>>  KB<<:>> Ampicillin S<<:>> Ceftriaxone S<<:>> Moxifloxacin S<<:>> Tetracycline I<<:>> Trimethoprim + Sulfamethoxazole S<<:>><<:>>",yes,yes,yes,14 m.o.,W,F,none,no,no,no,2.87,23.3,394,4.4,0.2,0.3,0.8,n/a,4.6,165,40,38.2,20,98/46,150,10,n/a,n/a,n/a,no,yes,yes,Peds ICU,sepsis,clindamycin(1 day),cefepime(1 day)<<.>> amoxicillin(1 day)<<.>> zosyn(3 days),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,Endotracheal tube tip appears to be coursing in the right mainstem <<:>>bronchus with leftward shift of the mediastinum and increased opacity of <<:>>the left hemithorax<<.>> compatible with atelectasis.<<:>>Round<<.>> smooth<<.>> and well circumscribed metallic density measuring <<:>>approximately 2 cm<<.>> compatible with a coin which appears to be within the <<:>>esophagus rather than trachea<<.>> based on size.<<:>>Nasogastric tube tip within the stomach.<<:>>Unremarkable visualized bowel gas pattern.<<:>>,see impression,Chest xray,T + 3,Comparison is made with the study of <<:>>the previous afternoon. Lung inflation has continued to improve<<.>> though <<:>>there continues to be generalized patchy infiltrate <<.>> particularly in the <<:>>left lower lobe. There is no atelectasis. Heart size is normal. NG tube <<:>>is in the stomach. Right subclavian catheter tip remains in the superior ,see impression,n/a,n/a,n/a,n/a
ETA305,August Justice,Porter,12/4/2014,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells and Light Squamous Epithelial Cells<<:>>Moderate Gram Negative Bacilli<<:>>Light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Cult <<:>>Positive<<:>>ORG 1:<<:>>Light Methicillin resistant Staphylococcus aureus<<:>><<:>><<:>>Respiratory Cult STAPHYLOCOCCUS AUREUS-MRSA<<:>>Respiratory Cult ENTEROBACTER CLOACAE<<:>><<:>><<:>>,Susceptibility <<:>>  Staphylococcus aureus-mrsa<<:>>  MIC<<:>> Clindamycin S<<:>> Erythromycin S<<:>> Linezolid S<<:>> Moxifloxacin R<<:>> Oxacillin R<<:>> Tetracycline S<<:>> Trimethoprim + Sulfamethoxazole S<<:>> Vancomycin S<<:>>   <<:>><<:>>Susceptibility <<:>>  Enterobacter cloacae<<:>>  MIC<<:>> Amikacin S<<:>> Ampicillin R<<:>> Ampicillin + Sulbactam R<<:>> Aztreonam S<<:>> Cefazolin R<<:>> Cefepime S<<:>> Cefoxitin R<<:>> Ceftazidime S<<:>> Ceftriaxone S<<:>> Ciprofloxacin S<<:>> Ertapenem S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tetracycline S<<:>> Tobramycin S<<:>> Trimethoprim + Sulfamethoxazole S<<:>><<:>>,yes,no(trach collar),yes,75,O,M,new infiltrate<<.>> increased white count<<.>> positive culture,yes,no,yes,11.33,26.1,527,3.1,0.38,0.6,n/a,n/a,n/a,n/a,40,37.9,33,121/59,69,unclear,n/a,n/a,n/a,no,yes,yes,NCCU,pneumonia,cefazolin( 2 days)<<.>> cefepime(> 2 weeks)<<.>> vancomycin( > 2 weeks),zosyn( 8 days),none,Respiratory,T + 5,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>Moderate Gram Positive Cocci in Clusters<<:>>Very light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Cult <<:>>Very Light Respiratory Flora<<:>>ORG 1:<<:>>Moderate Methicillin resistant Staphylococcus aureus<<:>>Staphylococcal isolates that are resistant to oxacillin should not be<<:>>treated with penicillins<<.>> beta-lactam/beta-lactamase inhibitor<<:>>combinations<<.>> carbapenems and cephalosporins<<.>> except cephalosporins<<:>>with anti-MRSA activity.<<:>><<:>><<:>>Respiratory Cult STAPHYLOCOCCUS AUREUS-MRSA<<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Staphylococcus aureus-mrsa<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Clindamycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Erythromycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Linezolid<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Moxifloxacin<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Oxacillin<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Vancomycin<<:>><<:>>S<<:>>,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,Feeding tube is now gone. NG tube sidehole ends in the stomach with tip <<:>><<:>>beyond the lower field-of-view. <<:>>Lines and tubes otherwise unchanged. <<:>>Trace bilateral pleural effusions. <<:>>Unchanged left mid to lower lung mild hazy opacities<<.>> which could <<:>>represent atelectasis but underlying infection is not ruled out<<.>> given <<:>>the asymmetry. <<:>>Minimal right basilar atelectasis ,atelectasis,Chest xray,T  0,NG tube has been removed since previous exam. Endotracheal tube replaced <<:>><<:>>with a tracheostomy tube. Right sided central venous catheter remains tip <<:>><<:>>in the SVC RA region. Increasing left effusion with some atelectatic <<:>>change and some increased parahilar interstitial markings noted. <<:>>Right-sided atelectasis and effusion also reflecting some progressive ,atelectasis,Chest xray,T + 5,Interval development of left lower lobe alveolar infiltrate<<.>> suggestive <<:>><<:>>of pneumonia. <<:>>Small left pleural effusion. <<:>>Probable small right pleural effusion comment decreasing compared to the <<:>><<:>>,see impression
ETA306,Stephen Shaffer,Stewart,2/22/2016,Gram Stain <<:>>Good specimen<<:>>Moderate Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>Moderate Gram Positive Cocci in Clusters<<:>>Light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Cult <<:>>Moderate Respiratory Flora<<:>>ORG 1:<<:>>Moderate Staphylococcus aureus<<:>>ORG 2:<<:>>Moderate Haemophilus influenzae<<:>>Beta-lactamase negative;<<:>><<:>><<:>>Respiratory Cult STAPHYLOCOCCUS AUREUS<<:>>Respiratory Cult HAEMOPHILUS INFLUENZAE<<:>><<:>>,<<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Staphylococcus aureus<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Clindamycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Erythromycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Moxifloxacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Oxacillin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Vancomycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Haemophilus influenzae<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Moxifloxacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>R<<:>>,yes,yes,yes,37,W,F,treated for possible VAP per notes,no,no,yes,13.07,37.1,215,n/a,0.4,0.6,n/a,< .10,n/a,n/a,40,37.9,18,105/59,94,unclear,n/a,n/a,n/a,no,yes,yes,MICU,pneumonia,acyclovir( 3 days)<<.>> ceftriaxone(7 days)<<.>> vancomycin( 3 days),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 3,Frontal views of the chest taken sequentially<<.>> labeled ETT placement 1 <<:>>and 2 <<:>><<:>>On the first examination at 1848 hours the endotracheal tube is within <<:>>the right mainstem bronchus. No evidence of consolidation. Minimal <<:>>elevation right hemidiaphragm. Top normal heart size. <<:>><<:>>On the second radiograph timed at 1850 hours endotracheal tube tip is at <<:>><<:>>the carina but pointed towards the right mainstem bronchus. <<:>>,see impression,Chest xray,T  0,No significant interval change. <<:>><<:>>Lines and tubes appear stable in position. <<:>>Normal heart size. <<:>>Lungs appear clear ,see impression,n/a,n/a,n/a,n/a
ETA307,Nigel Collins,Bruce,11/14/2016,<<:>>Gram Stain<<:>><<:>> <<:>><<:>><<:>>Good specimen <<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial <<:>>Cells <<:>>Moderate Normal Upper Respiratory Flora <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>> <<:>><<:>><<:>>Moderate Respiratory Flora <<:>>ORG 1: <<:>>Moderate Pseudomonas aeruginosa <<:>>ORG 2: <<:>>Moderate Pseudomonas aeruginosa <<:>>second morphology; <<:>>ORG 3: <<:>>Moderate Pseudomonas aeruginosa <<:>>third morphology; <<:>>ORG 4: <<:>>Moderate Pseudomonas aeruginosa <<:>>fourth morphology <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Pseudomonas aeruginosa <<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Pseudomonas aeruginosa <<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Pseudomonas aeruginosa <<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Pseudomonas aeruginosa <<:>>,Susceptibility <<:>>  Pseudomonas aeruginosa (2.1)<<:>>  MIC<<:>> Amikacin S<<:>> Aztreonam S<<:>> Cefepime S<<:>> Ceftazidime S<<:>> Ciprofloxacin S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tobramycin S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (2.2)<<:>>  MIC<<:>> Amikacin S<<:>> Aztreonam S<<:>> Cefepime S<<:>> Ceftazidime S<<:>> Ciprofloxacin S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam I<<:>> Tobramycin S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (2.3)<<:>>  MIC<<:>> Amikacin S<<:>> Aztreonam S<<:>> Cefepime S<<:>> Ceftazidime S<<:>> Ciprofloxacin S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tobramycin S<<:>>   <<:>><<:>>Susceptibility <<:>>  Pseudomonas aeruginosa (2.4)<<:>>  MIC<<:>> Amikacin S<<:>> Aztreonam S<<:>> Cefepime S<<:>> Ceftazidime S<<:>> Ciprofloxacin S<<:>> Gentamicin S<<:>> Meropenem S<<:>> Piperacillin + Tazobactam S<<:>> Tobramycin S<<:>><<:>>,yes,no(trach collar),,77,W,M,none,no,no,no,8.02,24.5,271,n/a,n/a,n/a,n/a,n/a,n/a,242,40,36.8,20,137/67,88,unclear,n/a,n/a,n/a,no,yes,yes,,unclear id diagnosis,none,none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T + 4,Tracheostomy. Persistent elevation of the right hemidiaphragm with right <<:>><<:>>basilar atelectasis. Persistent consolidation and volume loss at the <<:>>right upper lung with interval resolution consolidation within the right <<:>><<:>>mid to lower lung. Mild increased interstitial markings seen throughout <<:>><<:>>left chest. No worrisome osseous abnormalities are visualized. <<:>>Vertebroplasty cement is seen in the lower thoracic spine. <<:>>,see impression,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA308,Magee Golden,Castro,8/17/2016,Gram Stain <<:>>Adequate specimen<<:>>Light Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>No organisms seen.<<:>><<:>><<:>>Respiratory Culture (HH)<<:>>Respiratory Culture <<:>>Pseudomonas aeruginosa<<:>>Light<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Acinetobacter baumannii/calcoaceticus complex<<:>>Light<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Stenotrophomonas maltophilia<<:>>Very Light<<:>>second morphology;<<:>><<:>><<:>><<:>>,"Susceptibility <<:>>  Pseudomonas aeruginosa<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Aztreonam 16 ug/mL I<<:>> Cefepime 8 ug/mL S<<:>> Ceftazidime 8 ug/mL S<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Gentamicin 8 ug/mL"">>8 ug/mL R<<:>> Meropenem 8 ug/mL"">>8 ug/mL R<<:>> Piperacillin + Tazobactam 16/4 ug/mL S<<:>> Tobramycin 8 ug/mL"">>8 ug/mL R<<:>>   <<:>><<:>>Susceptibility <<:>>  Acinetobacter baumannii/calcoaceticus complex<<:>>  MIC<<:>> Amikacin <=8 ug/mL S<<:>> Ampicillin + Sulbactam 4/2 ug/mL S<<:>> Aztreonam 16 ug/mL"">>16 ug/mL R<<:>> Cefepime 4 ug/mL S<<:>> Ceftazidime 4 ug/mL S<<:>> Ciprofloxacin <=0.5 ug/mL S<<:>> Gentamicin 8 ug/mL"">>8 ug/mL R<<:>> Meropenem <=0.5 ug/mL S<<:>> Tetracycline 8 ug/mL"">>8 ug/mL R<<:>> Tobramycin 8 ug/mL"">>8 ug/mL R<<:>> Trimethoprim + Sulfamethoxazole 2/38 ug/mL"">>2/38 ug/mL R<<:>>   <<:>><<:>>Susceptibility <<:>>  Stenotrophomonas maltophilia<<:>>  MIC<<:>> Ceftazidime 16 ug/mL"">>16 ug/mL R<<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S<<:>><<:>>",yes,yes,yes,8,W,F,none,no,no,no,13.31,32.2,423,3.2,0.3,0.3,n/a,n/a,3.2,n/a,30,39.7,25,122/59,157,unclear,n/a,n/a,n/a,no,yes,yes,Peds ICU,unclear,gentamicin( 1 day)<<.>> cefazolin(8 days)<<.>> doxycycline(4 days),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 5,Small right subpulmonic hydropneumothorax appearing since prior exam on <<:>> with a tiny amount of air seen medial to the lung<<.>> against the <<:>>mediastinum.<<:>>Moderate hypoinflation.<<:>>Spinal distraction hardware overlying the thoracic and lumbar spine.<<:>><<:>>No other changes since prior exam.<<:>><<:>>Tracheostomy tube.<<:>>Ventriculoperitoneal shunt tubing overlies the right side<<.>> abdominal <<:>>catheter tip off image.<<:>>,see impression,Chest xray,T  0,Minimal increase in pulmonary edema and small right pleural effusion. <<:>>Otherwise no significant change compared to prior exam.<<:>>Tracheostomy cannula remains in functional position.<<:>>Posterior spinal growing rods<<.>> hardware intact.<<:>>VP shunt tubing superimposed on the midline neck<<.>> right chest and right <<:>>upper abdomen.<<:>>,see impression,Chest xray,T + 3,Unchanged since prior <<:>>Mild interstitial edema and hypoinflation of the lungs.<<:>>Blunting of the costophrenic angles bilaterally<<.>> likely reflecting trace <<:>>bilateral pleural effusions.<<:>>Unchanged cardiac silhouette.<<:>>Tracheostomy tube in functional position.<<:>>Bilateral thoracic growing rods partially visualized. Skin drains <<:>>previously present have been removed.<<:>>VP shunt tubing overlying the right chest.<<:>>,n/a
ETA309,Rigel George,Burks,10/9/2015,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>Moderate Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture (HH)<<:>>Respiratory Culture <<:>>Staphylococcus aureus<<:>>Heavy<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Haemophilus influenzae<<:>>Heavy<<:>>Beta lactamase negative<<:>> <<:>><<:>><<:>>,Susceptibility <<:>>  Staphylococcus aureus<<:>>  MIC<<:>> Clindamycin <=0.5 ug/mL S<<:>> Erythromycin <=0.5 ug/mL S<<:>> Moxifloxacin <=0.5 ug/mL S<<:>> Oxacillin 0.5 ug/mL S<<:>> Tetracycline <=0.5 ug/mL S<<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S<<:>> Vancomycin 1 ug/mL S<<:>>   <<:>><<:>>Susceptibility <<:>>  Haemophilus influenzae<<:>>  KB<<:>> Ampicillin I<<:>> Ceftriaxone S<<:>> Moxifloxacin S<<:>> Tetracycline S<<:>> Trimethoprim + Sulfamethoxazole S<<:>><<:>>,unclear(staph grew in sputum<<.>> but per notes<<.>> abx were no indidcated at that time),yes,yes,43,B,M,unclear,unclear,unclear,unclear,6.45,27.5,336,4.1,0.6,0.3,n/a,n/a,0.8,105,40,36,24,156/80,68,unclear,n/a,n/a,n/a,no,yes,yes,NCCU,unclear,cefazolin(9 days)<<.>> amantadine( > 2 weeks),ampicillin( 1 day)<<.>> zosyn( 1 day),none,Respiratory,T - 2,Gram Stain <<:>>Adequate specimen<<:>>Very Light Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>Very light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture Light Respiratory Flora (HH)<<:>>Respiratory Culture <<:>>Staphylococcus aureus<<:>>Moderate<<:>> (HH)<<:>><<:>>Respiratory Culture <<:>>Haemophilus influenzae<<:>>Moderate<<:>>Beta lactamase negative<<:>> <<:>><<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Staphylococcus aureus<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Clindamycin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Erythromycin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Moxifloxacin<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Oxacillin<<:>><<:>>0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>><=0.5 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>><=0.5/9.5 u...<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Vancomycin<<:>><<:>>1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Haemophilus influenzae<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>KB<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Moxifloxacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>>,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 6,Tip of the endotracheal tube located 4.6 cm above the carina. Right VP <<:>>shunt catheter traverses the right chest and extends into the right upper <<:>>quadrant. Right-sided PICC unchanged.<<:>><<:>>Stable enlargement of the cardiac silhouette.<<:>>Stable mild pulmonary vascular congestion.<<:>>No sizable pleural effusions.<<:>>Stable left basilar and retrocardiac opacities; favor atelectasis ,atelectasis,Chest xray,T  0,Endotracheal tube has been advanced<<.>> now with tip approximately 3 cm <<:>>above the carina. Otherwise<<.>> no significant change<<.>> except for exclusion <<:>>of left lower lateral chest wall.<<:>><<:>>Right PICC with tip in upper right atrium. Moderate cardiomegaly. <<:>>Probable trace left-sided pleural effusion and medial left lung base <<:>>atelectasis. VP shunt tubing coursing over right chest. Spine osteophytes ,see impression,Chest xray,T + 4,Lines and tubes are unchanged. Increasing alveolar opacities throughout <<:>>the lungs<<.>> now slightly more confluent in the right upper and left lower <<:>>lobes. Given the rapid progression<<.>> findings likely represent pulmonary <<:>>edema. Pneumonia can have a similar radiographic appearance. No <<:>>pneumothorax. ,possible pneumonia
ETA310,Coby Jacobson,Richmond,2/27/2015,,,,unclear,,72,W,M,,,,,,,,,,,,,,,unclear,unclear,unclear,unclear,unclear,unclear,,,,,,,,,unclear,unclear,unclear,,,,,,,,,,,,,,,,,,,,,,,,
ETA311,Aristotle Lewis,Roy,11/21/2015,Gram Stain <<:>>Adequate specimen<<:>>Moderate Polymorphonuclear Cells and Light Squamous Epithelial Cells<<:>>Very light Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Culture Light Respiratory Flora<<:>><<:>>,n/a,yes,yes,yes,64,B,F,none,no,no,no,4.12,25.5,111,3.2,1.7,0.8,0.8,n/a,n/a,86,60,35.7,16,106/50,86,unclear,n/a,n/a,n/a,no,yes,yes,Adult ICU,sepsis,Fluconazole( 4 days)<<.>> cefazolin(1 day)<<.>> vancomycin(> 2 weeks)<<.>> clindamycin( 1 day)<<.>> atovaquone(> 2 weeks)<<.>> aztreonam(2 days)<<.>> metronidazole( 2 days),Cefepime( 7 days)<<.>> oxacillin( 8 days)<<.>> zosyn(> 2 weeks),none,Blood,T + 1,Blood Culture <<:>>Gram stain positive for Gram Positive Cocci in Chains<<:>>Blood Culture <<:>>Enterococcus faecalis<<:>>in Aerobic Resin Bottle<<:>><<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Enterococcus  faecalis<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>>1 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin-Syn<<:>><<:>><=500 ug/mL<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Streptomycin-Syn<<:>><<:>>>1000 ug/mL<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Vancomycin<<:>><<:>>2 ug/mL<<:>><<:>>S<<:>><<:>><<:>><<:>>,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,New endotracheal tube is present with tip located within the right <<:>>mainstem bronchus. Stable left internal jugular venous catheter with tip <<:>>at the upper superior vena cava.<<:>>Airspace opacity within the left lung personally represent atelectasis <<:>>due to poor aeration of the left lung given endotracheal tube placement.<<:>><<:>><<:>>Endotracheal tube has been repositioned<<.>> now lying 3 cm above the carina. <<:>>Venous catheter unchanged.<<:>>Increased aeration of the left lung though there is persistent perihilar <<:>>consolidation.<<:>>No definite pleural effusion or pneumothorax.<<:>>Study is limited by shallow lung volumes ,see impression,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA312,Brock Gould,Snow,3/28/2016,cancelled,cancelled,yes,no(trach collar),,75,O,M,none,no,no,no,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,40,36.5,18,120/64,65,unclear,n/a,n/a,n/a,no,yes,yes,,unclear id diagnosis,none,none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA313,Ian Avila,Spears,3/9/2015,<<:>>Gram Stain<<:>><<:>> <<:>><<:>><<:>>Good specimen <<:>>Heavy Polymorphonuclear Cells and Very Light Squamous Epithelial Cells <<:>>Very light Gram Negative Bacilli <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>><<:>> (HH) <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Enterobacter cloacae <<:>>Moderate <<:>><<:>><<:>>(HH)<<:>> <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Enterobacter aerogenes <<:>>Heavy <<:>><<:>><<:>>(HH)<<:>> <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Enterobacter aerogenes <<:>>Heavy <<:>>second morphology; <<:>><<:>><<:>>(HH)<<:>> <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Acinetobacter baumannii/calcoaceticus complex <<:>>Heavy <<:>><<:>><<:>>,"Susceptibility <<:>>  Enterobacter cloacae <<:>>  MIC <<:>> Amikacin <=8 ug/mL S <<:>> Ampicillin 16 ug/mL"">>16 ug/mL R <<:>> Ampicillin + Sulbactam R <<:>> Aztreonam <=2 ug/mL S <<:>> Cefazolin R <<:>> Cefepime <=1 ug/mL S <<:>> Cefoxitin <=4 ug/mL R <<:>> Ceftazidime <=0.5 ug/mL S <<:>> Ceftriaxone <=1 ug/mL S <<:>> Ciprofloxacin <=0.5 ug/mL S <<:>> Ertapenem <=0.25 ug/mL S <<:>> Gentamicin <=2 ug/mL S <<:>> Meropenem <=0.5 ug/mL S <<:>> Piperacillin + Tazobactam <=2/4 ug/mL S <<:>> Tetracycline <=2 ug/mL S <<:>> Tobramycin <=2 ug/mL S <<:>> Trimethoprim + Sulfamethoxazole 2/38 ug/mL"">>2/38 ug/mL R <<:>>    <<:>><<:>>Susceptibility <<:>>  Enterobacter aerogenes (2)<<:>>  MIC KB<<:>> Amikacin <=8 ug/mL S <<:>> Ampicillin 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Ampicillin + Sulbactam 16/8 ug/mL"">>16/8 ug/mL R 16/8 ug/mL"" colSpan=""2""> <<:>> Aztreonam 8 ug/mL I <<:>> Cefazolin 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Cefepime <=1 ug/mL S <<:>> Cefoxitin 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Ceftazidime 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Ceftriaxone 16 ug/mL R <<:>> Ciprofloxacin <=0.5 ug/mL S <<:>> Ertapenem  S<<:>> Gentamicin <=2 ug/mL S <<:>> Meropenem <=0.5 ug/mL S <<:>> Piperacillin + Tazobactam 64/4 ug/mL I <<:>> Tetracycline <=2 ug/mL S <<:>> Tobramycin <=2 ug/mL S <<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S <<:>><<:>>",yes,no(trach collar),no,27,B,M,treated for HAP per notes,yes,no,no,14.91,29.6,320,n/a,n/a,n/a,1.8,n/a,n/a,109,28,37.7,40,126/88,124,6,n/a,n/a,n/a,no,yes,yes,Neurology,HAP,Cefepime( 11 day)<<.>> vancomycin(> 2 weeks)<<.>> zosyn( 3 days),bactrim( 3 days),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,No significant change since prior exam.<<:>><<:>>Tracheostomy. Right PICC with tip at junction SVC and right atrium. Left <<:>>upper quadrant G-tube. Ill-defined opacities bilateral medial lungs<<.>> more <<:>>so on the right than on the left<<.>> better characterized on recent CT of <<:>>the chest<<.>> concerning for an infectious process.<<:>>,possible infection,Chest xray,T  0,No significant change since prior exam.<<:>><<:>>Tracheostomy. Right PICC with tip not well seen<<.>> probably in lower SVC. <<:>>Lungs are clear.<<:>>,see impression,Chest xray,T + 7,<<:>>* Support devices: Tracheostomy tube with the tip over lying the mid <<:>>thoracic trachea. Right-sided PICC line with the tip overlying the <<:>>cavoatrial junction.<<:>><<:>>* Cardiomediastinal silhouette: No significant interval change given <<:>>differences in rotation.<<:>><<:>>* Lungs: No new confluent airspace process.<<:>><<:>>* Osseous structures: No change<<:>>,see impression
ETA314,Amal Dunlap,Ray,9/25/2016,<<:>>Gram Stain<<:>><<:>> <<:>><<:>><<:>>Good specimen <<:>>Heavy Polymorphonuclear Cells and Very Light Squamous Epithelial Cells <<:>>Very light Gram Negative Bacilli <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>><<:>> (HH) <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Enterobacter cloacae <<:>>Moderate <<:>><<:>><<:>>(HH)<<:>> <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Enterobacter aerogenes <<:>>Heavy <<:>><<:>><<:>>(HH)<<:>> <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Enterobacter aerogenes <<:>>Heavy <<:>>second morphology; <<:>><<:>><<:>>(HH)<<:>> <<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Acinetobacter baumannii/calcoaceticus complex <<:>>Heavy <<:>><<:>><<:>>,"Susceptibility <<:>>  Enterobacter cloacae <<:>>  MIC <<:>> Amikacin <=8 ug/mL S <<:>> Ampicillin 16 ug/mL"">>16 ug/mL R <<:>> Ampicillin + Sulbactam R <<:>> Aztreonam <=2 ug/mL S <<:>> Cefazolin R <<:>> Cefepime <=1 ug/mL S <<:>> Cefoxitin <=4 ug/mL R <<:>> Ceftazidime <=0.5 ug/mL S <<:>> Ceftriaxone <=1 ug/mL S <<:>> Ciprofloxacin <=0.5 ug/mL S <<:>> Ertapenem <=0.25 ug/mL S <<:>> Gentamicin <=2 ug/mL S <<:>> Meropenem <=0.5 ug/mL S <<:>> Piperacillin + Tazobactam <=2/4 ug/mL S <<:>> Tetracycline <=2 ug/mL S <<:>> Tobramycin <=2 ug/mL S <<:>> Trimethoprim + Sulfamethoxazole 2/38 ug/mL"">>2/38 ug/mL R <<:>>    <<:>><<:>>Susceptibility <<:>>  Enterobacter aerogenes (2)<<:>>  MIC KB<<:>> Amikacin <=8 ug/mL S <<:>> Ampicillin 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Ampicillin + Sulbactam 16/8 ug/mL"">>16/8 ug/mL R 16/8 ug/mL"" colSpan=""2""> <<:>> Aztreonam 8 ug/mL I <<:>> Cefazolin 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Cefepime <=1 ug/mL S <<:>> Cefoxitin 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Ceftazidime 16 ug/mL"">>16 ug/mL R 16 ug/mL"" colSpan=""2""> <<:>> Ceftriaxone 16 ug/mL R <<:>> Ciprofloxacin <=0.5 ug/mL S <<:>> Ertapenem  S<<:>> Gentamicin <=2 ug/mL S <<:>> Meropenem <=0.5 ug/mL S <<:>> Piperacillin + Tazobactam 64/4 ug/mL I <<:>> Tetracycline <=2 September ug/mL S <<:>> Tobramycin <=2 ug/mL S <<:>> Trimethoprim + Sulfamethoxazole <=0.5/9.5 u... S <<:>><<:>>",yes,no(trach collar),no,27,B,M,treated for HAP per notes,yes,no,no,14.91,29.6,320,n/a,n/a,n/a,1.8,n/a,n/a,109,28,37.7,40,126/88,124,6,n/a,n/a,n/a,no,yes,yes,Neurology,HAP,Cefepime( 11 day)<<.>> vancomycin(> 2 weeks)<<.>> zosyn( 3 days),bactrim( 3 days),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 7,No significant change since prior exam.<<:>><<:>>Tracheostomy. Right PICC with tip at junction SVC and right atrium. Left <<:>>upper quadrant G-tube. Ill-defined opacities bilateral medial lungs<<.>> more <<:>>so on the right than on the left<<.>> better characterized on recent CT of <<:>>the chest<<.>> concerning for an infectious process.<<:>>,possible infection,Chest xray,T  0,No significant change since prior exam.<<:>><<:>>Tracheostomy. Right PICC with tip not well seen<<.>> probably in lower SVC. <<:>>Lungs are clear.<<:>>,see impression,Chest xray,T + 7,<<:>>* Support devices: Tracheostomy tube with the tip over lying the mid <<:>>thoracic trachea. Right-sided PICC line with the tip overlying the <<:>>cavoatrial junction.<<:>><<:>>* Cardiomediastinal silhouette: No significant interval change given <<:>>differences in rotation.<<:>><<:>>* Lungs: No new confluent airspace process.<<:>><<:>>* Osseous structures: No change<<:>>,see impression
ETA315,Caleb Hess,Clark,5/17/2016,Gram Stain <<:>>Less than one polymorphonuclear leukocyte per squamous <<:>>epithelial cell; microscopically consistent with saliva; <<:>>cultured because specimen received from unique location <<:>>(i.e.oncology<<.>> transplant<<.>> etc.) or unable to be recollected.<<:>><<:>><<:>>Respiratory Culture Heavy Respiratory Flora (HH)<<:>>Respiratory Culture <<:>>Stenotrophomonas maltophilia<<:>>Heavy<<:>><<:>><<:>><<:>>,<<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Stenotrophomonas maltophilia<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>>16 ug/mL<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>1/19 ug/mL<<:>><<:>>S<<:>>,no,no(trach collar),yes,83,W,F,none,no,no,no,8.73,23.5,210,4,1.1,0.5,0.9,n/a,n/a,102,27,36.6,27,158/56,92,13,n/a,n/a,n/a,no,yes,yes,Adult ICU,sepsis,fluconazole(> 2 weeks)<<.>> ertapenem( 13 days)<<.>> vancomycin( > 2 weeks),cipro( 2 days),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 6,New tunneled right jugular central venous catheter terminating in region <<:>>of right atrium.<<:>>Interval removal of left PICC and left jugular central venous catheter.<<:>>Grossly unchanged diffuse bilateral interstitial opacities<<.>> possibly <<:>>representing interstitial edema<<.>> infection<<.>> and/or chronic changes.<<:>>Small bilateral pleural effusions. No pneumothorax. Mild biapical <<:>>scarring.<<:>>Unchanged mild cardiomegaly. Markedly atherosclerotic tortuous aorta.<<:>>Diffusely demineralized bones. Partially imaged lumbar levoscoliosis.<<:>>Right axillary clips.<<:>>,see impression,Chest xray,T  0,1. Large right and moderate left pleural effusions<<.>> increased compared to <<:>>prior study.<<:>>2. Scattered patchy consolidations and small amount of debris in the <<:>>trachea. Correlate for aspiration or pneumonia.<<:>>3. Postsurgical changes from Whipple procedure again seen. Percutaneous <<:>>catheters and biliary drain present. Small mount of fluid at the porta <<:>>hepatis and at the gastrojejunostomy<<.>> decreasing since the prior exam.<<:>>4. Low lying Foley catheter with balloon inflated in the urethra. <<:>>Recommend repositioning.<<:>>5. Extensive atherosclerotic disease ,pneumonia,Chest xray,T + 3,Small left pleural effusion is probably increased compared to previous <<:>><<:>><<:>>No other definite significant changes. Suboptimal study with oblique <<:>>patient position.<<:>><<:>>Vascular congestion. Interstitial abnormalities throughout both lungs <<:>>probably edema. Small right pleural effusion.<<:>><<:>>Cardiomegaly. Atherosclerosis with extensive aortic calcification.<<:>><<:>>Right venous catheter with tip near superior cavoatrial junction.<<:>><<:>>Right chest wall surgical clips. Degenerative bone changes and osteopenia ,see impression
ETA316,Aaron Parrish,Emerson,10/16/2016,Gram Stain <<:>>Good specimen<<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial<<:>>Cells<<:>>Heavy Gram Negative Bacilli<<:>>Moderate Normal Upper Respiratory Flora<<:>><<:>><<:>>Respiratory Cult <<:>>Moderate Respiratory Flora<<:>>ORG 1:<<:>>Heavy Klebsiella pneumoniae<<:>>ORG 2:<<:>>Heavy Klebsiella pneumoniae<<:>>second morphology;<<:>><<:>><<:>>Respiratory Cult Klebsiella pneumoniae<<:>>Respiratory Cult Klebsiella pneumoniae<<:>><<:>>,<<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Klebsiella pneumoniae (2.1)<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin + Sulbactam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefazolin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefoxitin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ertapenem<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Klebsiella pneumoniae (2.2)<<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>>R<<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin + Sulbactam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefazolin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Cefoxitin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Ertapenem<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>>S<<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>>,yes,yes,yes,84,W,F,none,no,no,no,20.8,30.3,234,4,2.2,3.1,n/a,n/a,n/a,216,40,33.1,35,107/68,103,unclear,n/a,n/a,n/a,no,yes,yes,CICU,no id diagnosis,zosyn(1 day)<<.>> vancomycin(1 day),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,1. Significant interval enlargement of a now moderate to large left-sided <<:>><<:>>pleural effusion with significant compressive atelectasis in the left <<:>>lung. <<:>>2. Hazy groundglass opacity and nodularity in the right upper lobe<<.>> with <<:>><<:>>relative sparing of the right middle and lower lobes<<.>> likely infectious <<:>><<:>>or inflammatory in etiology<<.>> although asymmetric pulmonary edema could <<:>>potentially have this appearance <<:>>,possible infection,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA317,Emmanuel Fischer,Frederick,8/18/2015,Gram Stain <<:>>Adequate specimen<<:>>Very Light Polymorphonuclear Cells and No Squamous Epithelial Cells<<:>>No organisms seen.<<:>><<:>><<:>>Respiratory Culture <<:>>Heavy Respiratory Flora<<:>><<:>><<:>><<:>>Respiratory Culture<<:>><<:>> <<:>><<:>><<:>>Neisseria meningitidis <<:>>Heavy <<:>>Beta lactamase negative<<:>> ,n/a,no(suspected tracheitis),no(trach collar),no,14,W,F,none, no,no,no,n/a,n/a,n/a,4.9,0.5,0.5,n/a,n/a,n/a,n/a,20,37.2,31,99/61,120,15,n/a,n/a,n/a,no,yes,yes,Peds Ortho,tracheitis,none,none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T - 1,Decreased inflation since the prior exam<<.>> now with moderate hypoinflation.<<:>>Retrocardiac opacity compatible with subsegmental atelectasis.<<:>>Patient is rotated to the left.<<:>>Otherwise unchanged.<<:>>Tracheostomy catheter with tip below the thoracic inlet<<.>> 3 cm above the <<:>>carina.<<:>>Discoid atelectasis left lower lateral lung.<<:>>Left-sided vagal nerve stimulator.<<:>>Dextroscoliosis thoracic spine.<<:>>No evidence of pneumothorax or pleural effusion.<<:>>Vagal nerve stimulator with electrodes in the left lateral neck region in <<:>>typical location.<<:>>,see impression,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA318,Allistair Stone,Duke,11/29/2015,Gram Stain<<.>> Respiratory Good specimen<<:>>Gram Stain<<.>> Respiratory Heavy Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Gram Stain<<.>> Respiratory Very light Normal Upper Respiratory Flora<<:>>Respiratory Culture Very Light Respiratory Flora<<:>><<:>>,n/a,,yes,yes,71,B,F,,,,,3.5,45.8,91,3.6,0.9,2,n/a,n/a,0,70.8,50,36.5,13,113/62,74,unclear,n/a,n/a,n/a,,,yes,HICU,,zosyn(7 days)<<.>>cefazolin(1 day),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest ct,T - 1,the segmental arteries.<<:>><<:>>2. No thoracic aorta dissection. <<:>><<:>>3. Opacification of the lower lobes. While some of this is related to <<:>>atelectasis<<.>> there is abnormal enhancement of the lungs with regions of <<:>>lower attenuation particularly in the left lower lobe suspicious for a <<:>>superimposed airspace process such as pneumonia. Aspiration pneumonia is <<:>>not excluded. Small bilateral pleural effusions are noted.<<:>>,possible pneumonia,Chest xray,T + 6,Frontal view of the chest compared to previous examination <<:>>. The heart size is stable. Endotracheal tube and nasogastric <<:>>tube in place. Low lung volumes. There is improved aeration of the lungs <<:>>compared to previous examination.<<:>><<:>>,see impression,n/a,n/a,n/a,n/a
ETA319,Avram Ball,Key,9/26/2016,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells and Very Light Squamous Epithelial Cells<<:>>Light Gram Positive Cocci<<:>>Light Gram Positive Bacilli<<:>><<:>><<:>>Respiratory Cult <<:>>Positive<<:>>ORG 1:<<:>>Moderate Methicillin resistant Staphylococcus aureus<<:>>Staphylococcal isolates that are resistant to oxacillin should not be<<:>>treated with penicillins<<.>> beta-lactam/beta-lactamase inhibitor<<:>>combinations<<.>> carbapenems and cephalosporins<<.>> except cephalosporins<<:>>with anti-MRSA activity.<<:>>ORG 2:<<:>>Moderate Corynebacterium striatum<<:>><<:>><<:>>Respiratory Cult STAPHYLOCOCCUS AUREUS-MRSA<<:>>Respiratory Cult CORYNEBACTERIUM STRIATUM<<:>><<:>>,Susceptibility <<:>>  Staphylococcus aureus-mrsa<<:>>  MIC<<:>> Clindamycin R<<:>> Erythromycin R<<:>> Linezolid S<<:>> Moxifloxacin R<<:>> Oxacillin R<<:>> Tetracycline S<<:>> Trimethoprim + Sulfamethoxazole S<<:>> Vancomycin S<<:>><<:>>,yes,no(trach collar),no,65,W,F,treated for HAP per notes,no,no,no,14.32,28.8,307,n/a,n/a,n/a,n/a,n/a,n/a,n/a,40,37,20,109/57,80,unclear,n/a,n/a,n/a,no,yes,yes,Plaza,pneumonia,vancomycin(> 2 weeks),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T + 3,A frontal view of the chest was obtained. The lungs are low in <<:>><<:>>volume<<.>> with minimal basilar atelectatic change.. Tracheostomy tube is <<:>>overlying the upper trachea. No focal consolidation to suggest pneumonia. <<:>><<:>>No pleural effusion. Heart is normal in size. Atherosclerotic plaque <<:>>noted in the thoracic aorta. ,see impression,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA320,Ciaran Howard,Brennan,9/13/2015,Gram Stain <<:>>Good specimen<<:>>Heavy Polymorphonuclear Cells 5/5/2043 and No Squamous Epithelial Cells<<:>>Very light Yeast;<<:>><<:>><<:>>Respiratory Cult <<:>>Very Light Respiratory Flora<<:>>ORG 1:<<:>>Very Light Serratia marcescens<<:>>ORG 2:<<:>>Aspergillus niger<<:>>Identification performed by the Mycology Lab<<:>><<:>><<:>>Respiratory Cult SERRATIA MARCESCENS<<:>>Respiratory Cult ASPERGILLUS NIGER<<:>><<:>>,Susceptibility <<:>>  Serratia marcescens <<:>>  MIC <<:>> Amikacin S <<:>> Ampicillin R <<:>> Ampicillin + Sulbactam R <<:>> Aztreonam S <<:>> Cefazolin R <<:>> Cefepime S <<:>> Cefoxitin R <<:>> Ceftazidime S <<:>> Ceftriaxone S <<:>> Ciprofloxacin S <<:>> Ertapenem S <<:>> Gentamicin S <<:>> Meropenem S <<:>> Piperacillin + Tazobactam S <<:>> Tetracycline R <<:>> Tobramycin S <<:>><<:>>,no,yes,yes,54,B,M,none,no,no,no,14.54,39.5,183,3.7,0.9,0.4,n/a,n/a,n/a,145,40,38.5,20,unclear,122,unclear,n/a,n/a,n/a,unclear,unclear,yes,Burn ICU,no id diagnosis,clindamycin(1 day),none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,Endotracheal tube tip above the carina at the clavicle level. NG tube <<:>>present. No focal infiltrate or congestion. Heart and regional osseous <<:>>structures appropriate for age <<:>>,see impression,Chest xray,T + 6,Decrease in trace left-sided pleural effusion. <<:>>No other change. <<:>><<:>>Mild cardiomegaly. <<:>>Endotracheal tube and weighted tip feeding tube unchanged. <<:>>,see impression,n/a,n/a,n/a,n/a
ETA321,Drew Atkinson,Bartlett,2/11/2016,<<:>>Gram Stain<<:>><<:>> <<:>><<:>><<:>>Good specimen <<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial <<:>>Cells <<:>>Heavy Normal Upper Respiratory Flora <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Heavy Respiratory Flora <<:>>,n/a,no,yes,yes,60,W,M,none,no,no,no,6.59,32.6,77,4.7,2.6,0.7,n/a,n/a,n/a,102,40,37.7,20,unclear,132,unclear,n/a,n/a,n/a,no,yes,yes,Burn ICU,unclear id diagnosis,none,vancomycin(1 day),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,Endotracheal tube appears advanced slightly since the prior study with <<:>><<:>>the tip now at the carina and possibly within the proximal right mainstem <<:>><<:>>bronchus. Suggest withdrawing endotracheal tube slightly. Otherwise no <<:>>significant change since the prior study. <<:>><<:>>,see impression,Chest xray,T + 7,Medical apparatus unchanged. Slight improvement in aeration with some <<:>>minimal residual increased interstitial markings on a portable exam <<:>>,see impression,n/a,n/a,n/a,n/a
ETA322,Lucian Pacheco,Underwood,6/22/2016,Gram Stain <<:>>Good specimen<<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial<<:>>Cells<<:>>Moderate Gram Negative Diplococci<<:>><<:>><<:>>Respiratory Cult <<:>>Positive<<:>>ORG 1:<<:>>Moderate Klebsiella pneumoniae<<:>>ORG 2:<<:>>Moderate Acinetobacter baumannii/calcoaceticus complex<<:>><<:>><<:>>Respiratory Cult Klebsiella pneumoniae<<:>>Respiratory Cult Acinetobacter bauman/calc cplx<<:>><<:>>,<<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Klebsiella pneumoniae<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin<<:>><<:>>R<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin + Sulbactam<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>R<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Cefazolin<<:>><<:>>R<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Cefoxitin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>R<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftriaxone<<:>><<:>>R<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>>I<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ertapenem<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Piperacillin + Tazobactam<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>><<:>> <<:>> <<:>><<:>><<:>><<:>>Susceptibility <<:>><<:>><<:>><<:>><<:>> <<:>><<:>><<:>>Acinetobacter bauman/calc cplx<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>><<:>>MIC<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Amikacin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ampicillin + Sulbactam<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Aztreonam<<:>><<:>>R<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Cefepime<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ceftazidime<<:>><<:>>I<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Ciprofloxacin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Gentamicin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Meropenem<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Tetracycline<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Tobramycin<<:>><<:>>S<<:>><<:>> <<:>><<:>><<:>> <<:>><<:>>Trimethoprim + Sulfamethoxazole<<:>><<:>>S<<:>>,yes,yes,yes,38,O,F,concern for tracheitis vs VAP,no,no,yes,10.58,37.8,301,3.7,0.9,0.5,n/a,n/a,n/a,n/a,40,36.9,20,113/79,91,unclear,n/a,n/a,n/a,no,yes,yes,PCU,pneumonia,none,none,none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,There is mild atelectasis at the left lung base. No definite evidence of <<:>><<:>>pneumonia or focal consolidation. Improved aeration of the lungs since <<:>>the prior study . Top normal-sized heart. No acute pulmonary <<:>><<:>>edema. Tracheostomy tube. <<:>>,atelectasis,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
ETA323,Hyatt Huber,Ferguson,3/4/2015,<<:>>Gram Stain<<:>><<:>> <<:>><<:>><<:>>Good specimen <<:>>Moderate Polymorphonuclear Cells and Very Light Squamous Epithelial <<:>>Cells <<:>>Heavy Normal Upper Respiratory Flora <<:>><<:>><<:>><<:>><<:>><<:>>Respiratory Cult<<:>><<:>><<:>> Heavy Respiratory Flora <<:>>,n/a,no,yes,yes,60,W,M,none,no,no,no,6.59,32.6,77,4.7,2.6,0.7,n/a,n/a,n/a,102,40,37.7,20,unclear,132,unclear,n/a,n/a,n/a,no,yes,yes,Burn ICU,unclear id diagnosis,none,vancomycin(1 day),none,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Chest xray,T  0,Endotracheal tube appears advanced slightly since the prior study with <<:>><<:>>the tip now at the carina and possibly within the proximal right mainstem <<:>><<:>>bronchus. Suggest withdrawing endotracheal tube slightly. Otherwise no <<:>>significant change since the prior study. <<:>><<:>>,see impression,Chest xray,T + 7,Medical apparatus unchanged. Slight improvement in aeration with some <<:>>minimal residual increased interstitial markings on a portable exam <<:>>,see impression,n/a,n/a,n/a,n/a
